ARA-290は、炎症調節、組織保護、細胞ストレス応答研究における役割が研究されている合成ペプチドです。その標的ペプチド構造により、神経学的、代謝的、再生系の研究プログラムで注目を集めています。
私たちのARA-290 10mgは高純度と精密なペプチド組成、安定的かつ再現性の高い研究成果の確保。各バイアルは輸送や保管中の湿気、光、温度の変動から守られるよう丁寧に梱包されています。
ARA-290は、炎症、神経生物学、組織保護研究に関わる先進的な研究機関やディストリビューターに適しています。
ARA-290 is a peptide derivative of erythropoietin (EPO) that has shown significant promise in decreasing inflammatory pathways and enhancing repair mechanisms through its action on the innate repair receptors. This peptide, also known as cibinetide, has demonstrated various beneficial effects in clinical research, including reducing HbA1c levels, improving cholesterol profiles, modulating neuropathic pain, and accelerating wound healing. Product Usage: ARA-290 is strictly intended for use as a research chemical. It is designated for in vitro testing and laboratory experimentation only. Introduction into humans or animals is prohibited by law, and it should only be handled by licensed, qualified professionals. This product is not approved as a drug, food, or cosmetic. Introduction ARA-290 is a synthetic variant of the helix beta domain of erythropoietin, designed to harness the neuroprotective and analgesic effects of EPO without promoting red blood cell production. This peptide has progressed through phase II clinical trials and is preparing for phase III trials targeting several applications, including diabetes management and autoimmune sarcoidosis. Comprehensive Overview and Research Applications Neuroprotection and Neuropathic Pain ARA-290 has emerged as a potent neuroprotective agent, offering significant benefits in diabetic neuropathy and potentially other neurodegenerative conditions. Unlike traditional erythropoietin, which can lead to excessive red blood cell production, ARA-290 targets only the protective pathways, alleviating pain without the associated hematologic risks. Cardiovascular and Vascular Health ARA-290’s effects extend to cardiovascular health, particularly in protecting against retinal ischemia—a common cause of blindness. By safeguarding endothelial cells and promoting their regeneration, ARA-290 could significantly reduce the burden of vascular diseases. Additionally, its ability to enhance the survival and function of endothelial colony-forming cells could revolutionize treatments for vascular injuries and ischemic conditions. Inflammation and Immune Modulation The peptide’s role in reducing inflammatory cytokines and modulating the immune response has implications for transplant medicine, particularly in the survival of transplanted islet cells for diabetes treatment. By inhibiting macrophage activation and cytokine production, ARA-290 could improve the outcomes of cellular transplants and reduce the incidence of rejection. Tissue Protection and Wound Healing ARA-290 has shown potential in speeding up the wound healing process, particularly in chronic conditions like diabetes, where slow healing leads to complications. Its ability to stimulate tissue repair and reduce scarring could make it a valuable asset in managing and treating skin injuries and surgical wounds.Peptidegurusは、アメリカ製の研究ペプチドの大手サプライヤーであり、競争力のある価格で最高品質の製品を提供しています。卓越性と顧客サービスに重点を置いて、彼らはグローバルな配送で安全で便利な注文プロセスを保証します。
©Copyright Peptide Gurus2024。AllRights Reserved。プライバシーポリシー 本サイトのすべての製品は研究・開発用途のみを対象としています。製品は人間の消費物ではありません。このウェブサイトに記載されている声明は、米国食品医薬品局(FDA)やカナダ保健省によって評価されていません。本社の声明および製品は、いかなる病気の診断、治療、治癒、予防を目的としたものではありません。PeptideGurusは化学薬品の供給業者です。PeptideGurusは、連邦食品医薬品化粧品法503A条に基づく調剤薬局や化学調剤施設ではありません。Peptide Sciencesは連邦食品医薬品化粧品法503B条に基づくアウトソーシング施設ではありません。
接触
